Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01162031
Brief Title: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

First Submitted : July 12, 2010
First Submitted that Met QC Criteria : July 13, 2010
First Posted : July 14, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : May 16, 2018
Last Update Posted : May 21, 2018